Corneal Pachymetry Market size was valued at USD 333.7 million in 2021 and is projected to reach USD 424.7 million by 2028 at a CAGR of 4.1% during the forecast period 2022 to 2028. Due to increase in prevalence of eye disorders such as glaucoma, diabetic retinopathy. Moreover, increase in geriatric population, advancements in R&D activities and improved healthcare services are the major factors that are driving the growth of the market over the forecast time frame. The report studies market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global corneal pachymetry market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
Key Market Developments:
In March 2021, Iridex Corporation, a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases has entered into a strategic collaboration with Topcon Corporation.